Aptose Biosciences Inc (APS) — Financial Flexibility Index
Aptose Biosciences Inc (APS) has a Financial Flexibility Index of -0.29x as of September 2025. Free cash flow of CA$-7.41 Million (operating CF CA$-7.41 Million minus capex CA$0.00) represents 0% of total liabilities (CA$25.79 Million). Check Aptose Biosciences Inc (APS) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Aptose Biosciences Inc Financial Flexibility Index (1996–2024)
Historical Financial Flexibility Index trend for Aptose Biosciences Inc across 29 annual periods. For the full cash flow conversion analysis, see Aptose Biosciences Inc (APS) cash conversion ratio.
Annual Financial Flexibility Index for Aptose Biosciences Inc (1996–2024)
Year-by-year free cash flow to debt coverage for Aptose Biosciences Inc. Explore Aptose Biosciences Inc (APS) debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (CAD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -2.45x | CA$-35.97 Million | CA$-35.98 Million | CA$14.67 Million | ▲ +12.6% |
| 2023 | -2.80x | CA$-44.56 Million | CA$-44.59 Million | CA$15.89 Million | ▼ -15.4% |
| 2022 | -2.43x | CA$-32.30 Million | CA$-32.32 Million | CA$13.29 Million | ▲ +53.2% |
| 2021 | -5.20x | CA$-43.09 Million | CA$-43.30 Million | CA$8.29 Million | ▼ -13.0% |
| 2020 | -4.60x | CA$-33.81 Million | CA$-33.89 Million | CA$7.35 Million | ▼ -40.5% |
| 2019 | -3.28x | CA$-21.46 Million | CA$-21.56 Million | CA$6.55 Million | ▲ +60.1% |
| 2018 | -8.20x | CA$-22.88 Million | CA$-23.21 Million | CA$2.79 Million | ▼ -41.8% |
| 2017 | -5.78x | CA$-10.21 Million | CA$-10.22 Million | CA$1.76 Million | ▲ +37.4% |
| 2016 | -9.23x | CA$-12.17 Million | CA$-12.17 Million | CA$1.32 Million | ▼ -63.2% |
| 2015 | -5.66x | CA$-9.63 Million | CA$-9.89 Million | CA$1.70 Million | ▼ -18.0% |
| 2014 | -4.80x | CA$-9.64 Million | CA$-9.94 Million | CA$2.01 Million | ▼ -71.9% |
| 2013 | -2.79x | CA$-4.92 Million | CA$-4.94 Million | CA$1.76 Million | ▼ -126.1% |
| 2012 | -1.23x | CA$-3.21 Million | CA$-3.21 Million | CA$2.60 Million | ▲ +75.7% |
| 2011 | -5.08x | CA$-6.03 Million | CA$-6.03 Million | CA$1.19 Million | ▼ -288.5% |
| 2010 | -1.31x | CA$-3.52 Million | CA$-3.53 Million | CA$2.70 Million | ▼ -195.0% |
| 2009 | -0.44x | CA$-6.46 Million | CA$-6.62 Million | CA$14.57 Million | ▲ +32.4% |
| 2008 | -0.66x | CA$-10.19 Million | CA$-10.25 Million | CA$15.55 Million | ▼ -53.8% |
| 2007 | -0.43x | CA$-5.87 Million | CA$-5.88 Million | CA$13.76 Million | ▲ +54.0% |
| 2006 | -0.93x | CA$-11.80 Million | CA$-11.87 Million | CA$12.73 Million | ▲ +26.9% |
| 2005 | -1.27x | CA$-14.44 Million | CA$-14.92 Million | CA$11.40 Million | ▲ +0.0% |
| 2004 | -1.27x | CA$-14.44 Million | CA$-14.92 Million | CA$11.40 Million | ▲ +73.3% |
| 2003 | -4.75x | CA$-20.32 Million | CA$-20.60 Million | CA$4.28 Million | ▼ -42.6% |
| 2002 | -3.33x | CA$-7.48 Million | CA$-7.79 Million | CA$2.25 Million | ▲ +0.0% |
| 2001 | -3.33x | CA$-7.48 Million | CA$-7.79 Million | CA$2.25 Million | ▼ -105.9% |
| 2000 | -1.62x | CA$-6.17 Million | CA$-6.28 Million | CA$3.81 Million | ▼ -1947.7% |
| 1999 | 0.09x | CA$210.90K | CA$-3.58 Million | CA$2.41 Million | ▲ +103.2% |
| 1998 | -2.77x | CA$-2.44 Million | CA$-2.44 Million | CA$881.66K | ▲ +27.5% |
| 1997 | -3.82x | CA$-2.88 Million | CA$-3.02 Million | CA$755.18K | ▼ -16.7% |
| 1996 | -3.27x | CA$-2.61 Million | CA$-2.61 Million | CA$798.14K | — |